Search hospitals > New Hampshire > Manchester
Elliot Hospital
Claim this profileManchester, New Hampshire 03103
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
40 reported clinical trials
1 medical researcher
Summary
Elliot Hospital is a medical facility located in Manchester, New Hampshire. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Elliot Hospital is involved with conducting 40 clinical trials across 89 conditions. There are 1 research doctors associated with this hospital, such as Brian R. Knab.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at Elliot Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Low Testosterone
Progesterone Receptor Positive
Tumor Markers
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Elliot Hospital?
Elliot Hospital is a medical facility located in Manchester, New Hampshire. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Elliot Hospital is involved with conducting 40 clinical trials across 89 conditions. There are 1 research doctors associated with this hospital, such as Brian R. Knab.